Home/Pipeline/TSH‑001

TSH‑001

Presbyopia

Phase 1/2Active

Key Facts

Indication

Presbyopia

Phase

Phase 1/2

Status

Active

Company

About TSH Biopharm

Taiwan biotech delivering liquid‑biopsy diagnostics and a first‑in‑class presbyopia therapeutic.

View full company profile

Therapeutic Areas

Ophthalmology Oncology

Other Presbyopia Drugs

Drug	Company	Phase	Status
Presbyopia Treatment	Viatris (2)	NDA Submitted	Active
Presbyopia-Correcting ICL	STAAR Surgical	Research & Development	Active R&D
LB-01	Lento Bio	Discovery/IND-Enabling	Active
LB-02	Lento Bio	Discovery	Active
Presbyopia-Correcting Contact Lenses	Clerio Vision	Development	Active
Intra-corneal Implant	MAG Optics	Pre-clinical	Active
NVK029	Vyluma	Phase 2	Active
ArtiPlus	Ophtec	Clinical Trials	Active
BRIMOCHOL™ PF	Tenpoint Therapeutics	NDA Submitted	Active
Qlosi™	Orasis Pharmaceuticals	Approved	Active
DE-128A	Santen Pharmaceutical	Phase 2	Active
YP-10	Viatris	NDA Filed	Under FDA Review (PDUFA date set)